Literature DB >> 366103

Pharmacokinetic evaluation of hemodialysis in acute drug overdose.

S Takki, J G Gambertoglio, D H Honda, T N Tozer.   

Abstract

Entities:  

Mesh：

Year:  1978        PMID： 366103     DOI： 10.1007/bf01062724

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN： 0090-466X


× No keyword cloud information.
  87 in total

1.  Methaqualone pharmacokinetics after single- and multiple-dose administration in man.

Authors:  R K Nayak; R D Smyth; J H Chamberlain; A Polk; A F DeLong; T Herczeg; P B Chemburkar; R S Joslin; N H Reavey-Cantwell
Journal:  J Pharmacokinet Biopharm       Date:  1974-04

2.  Elimination of digoxin during maintenance haemodialysis.

Authors:  E Iisalo; J Forsström
Journal:  Ann Clin Res       Date:  1974-08

3.  Bioavailability studies of acetaminophen and nitrofurantoin.

Authors:  K S Albert; A J Sedman; P Wilkinson; R G Stoll; W J Murray; J G Wagner
Journal:  J Clin Pharmacol       Date:  1974 May-Jun       Impact factor: 3.126

4.  Kinetics of diphenylhydantoin in uraemic patients: consequences of decreased plasma protein binding.

Authors:  I Odar-Cederlöf; O Borgå
Journal:  Eur J Clin Pharmacol       Date:  1974       Impact factor: 2.953

Review 5.  Hemodialysis in children: technique, kinetic aspects related to varying body size, and application to salicylate intoxication, acute renal failure and some other disorders.

Authors:  R J Kallen; S Zaltzman; F L Coe; J Metcoff
Journal:  Medicine (Baltimore)       Date:  1966-01       Impact factor: 1.889

6.  [Severe meprobamate poisoning treated by hemodialysis and peritoneal dialysis].

Authors:  J Graae; J Ladefoged
Journal:  Nord Med       Date:  1969-05-08

7.  Acute massive chloral hydrate intoxication treated with hemodialysis: a clinical pharmacokinetic analysis.

Authors:  N E Stalker; J G Gambertoglio; C J Fukumitsu; J L Naughton; L Z Benet
Journal:  J Clin Pharmacol       Date:  1978 Feb-Mar       Impact factor: 3.126

8.  Hemodialysis in methyprylon poisoning.

Authors:  G Xanthaky; A W Freireich; W Matusiak; L Lukash
Journal:  JAMA       Date:  1966-12-12       Impact factor: 56.272

9.  Pharmacokinetics of salicylate elimination in man.

Authors:  G Levy
Journal:  J Pharm Sci       Date:  1965-07       Impact factor: 3.534

Review 10.  Pathophysiological and disease-induced changes in drug distribution volume: pharmacokinetic implications.

Authors:  U Klotz
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447
View more
  14 in total

Review 1.  Pharmacokinetics of haemoperfusion for drug overdose.

Authors:  S Pond; J Rosenberg; N L Benowitz; S Takki
Journal:  Clin Pharmacokinet       Date:  1979 Sep-Oct       Impact factor: 6.447

2.  Pharmacokinetics of amoxycillin and clavulanic acid in haemodialysis patients following intravenous administration of Augmentin.

Authors:  B E Davies; R Boon; R Horton; F C Reubi; C E Descoeudres
Journal:  Br J Clin Pharmacol       Date:  1988-10       Impact factor: 4.335

Review 3.  Clinical pharmacokinetics of oral activated charcoal in acute intoxications.

Authors:  P J Neuvonen
Journal:  Clin Pharmacokinet       Date:  1982 Nov-Dec       Impact factor: 6.447

4.  Deconvolution applied to the kinetics of extracorporal drug removal. Haemodialysis of cefsulodin.

Authors:  W R Gillespie; P Veng-Pedersen; T P Gibson
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

5.  Effect of activated charcoal on absorption and elimination of phenobarbitone, carbamazepine and phenylbutazone in man.

Authors:  P J Neuvonen; E Elonen
Journal:  Eur J Clin Pharmacol       Date:  1980-01       Impact factor: 2.953

6.  Phenobarbitone elimination rate after oral charcoal.

Authors:  P J Neuvonen; E Elonen
Journal:  Br Med J       Date:  1980-03-15

7.  Removal of imipenem and cilastatin by hemodialysis in patients with end-stage renal failure.

Authors:  K Konishi; H Suzuki; T Saruta; M Hayashi; N Deguchi; H Tazaki; A Hisaka
Journal:  Antimicrob Agents Chemother       Date:  1991-08       Impact factor: 5.191

8.  Extracorporeal therapy for dabigatran removal in the treatment of acute bleeding: a single center experience.

Authors:  Tripti Singh; Thin Thin Maw; Brian L Henry; Núria M Pastor-Soler; Mark L Unruh; Kenneth R Hallows; Thomas D Nolin
Journal:  Clin J Am Soc Nephrol       Date:  2013-05-23       Impact factor: 8.237

9.  Drug dosage in end-stage renal disease (ESRD) patients undergoing haemodialysis. A predictive study based on a microcomputer program.

Authors:  M V Mac-Kay; J Sanchez Burson; J Martinez-Lanao; A Dominguez-Gil
Journal:  Clin Pharmacokinet       Date:  1993-09       Impact factor: 6.447

Review 10.  Drug therapy in patients undergoing haemodialysis. Clinical pharmacokinetic considerations.

Authors:  C S Lee; T C Marbury
Journal:  Clin Pharmacokinet       Date:  1984 Jan-Feb       Impact factor: 6.447
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.